Cargando…
A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants
AIMS: We aimed to evaluate bleeding risk in clinical practice in patients with atrial fibrillation (AF) being prescribed dabigatran, rivaroxaban, or apixaban compared with warfarin. METHODS: Using nationwide registries (Norwegian Patient Registry and Norwegian Prescription Database), we identified A...
Autores principales: | Halvorsen, Sigrun, Ghanima, Waleed, Fride Tvete, Ingunn, Hoxmark, Cecilie, Falck, Pål, Solli, Oddvar, Jonasson, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216196/ https://www.ncbi.nlm.nih.gov/pubmed/27680880 http://dx.doi.org/10.1093/ehjcvp/pvw031 |
Ejemplares similares
-
Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation
por: Rutherford, Ole-Christian Walter, et al.
Publicado: (2022) -
New score for assessing bleeding risk in patients with atrial fibrillation treated with NOACs
por: Rutherford, Ole-Christian Walter, et al.
Publicado: (2018) -
Changes in primary care management of atrial fibrillation patients following the shift from warfarin to non-vitamin K antagonist oral anticoagulants: a Norwegian population based study
por: Halvorsen, Sigrun, et al.
Publicado: (2022) -
A 3-year survey quantifying the risk of dose escalation of benzodiazepines and congeners to identify risk factors to aid doctors to more rationale prescribing
por: Tvete, Ingunn Fride, et al.
Publicado: (2013) -
Risk factors for excessive benzodiazepine use in a working age population: a nationwide 5-year survey in Norway
por: Fride Tvete, Ingunn, et al.
Publicado: (2015)